manufacturing
3 articles tagged with ‘manufacturing’
Oligonucleotide Drug Product Development and Manufacturing
Facilities support parenteral drug product development and manufacturing for oligonucleotide drugs from preclinical to commercial stages. Teams handle 85,000+ characterization tests yearly across 5 production lines with 70 million units annual capacity. Services cover advanced formulations like lipid nanoparticles, high potency injectables, and clinical supplies for phases I to IV.
Why Research Peptides Vary in Price: Manufacturing Complexity Breakdown
Research peptides show wide price differences per mg, such as GHK-Cu being cheaper than retatrutide or BPC-157 less costly than tesamorelin. These variations stem from manufacturing challenges in solid-phase peptide synthesis, including sequence length, modifications, and purification needs. Understanding these factors helps researchers assess value across suppliers.
Oligonucleotide CRDMO Platform: Discovery to Commercial Manufacturing
This platform delivers full CRDMO services for oligonucleotides, covering discovery synthesis at nmol-mmol scales up to mol-scale commercial production. It includes monomers, linkers, ligands, conjugates, formulation, analytical testing, and CMC dossier preparation under a single quality system. Capabilities span DNA, ASOs, siRNAs, and more, with global regulatory approvals from FDA, EMA, and others.